GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 204 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2022. The put-call ratio across all filers is 1.05 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,638,000 | -40.9% | 151,800 | +60.1% | 0.37% | -40.2% |
| Q4 2021 | $2,771,000 | +399.3% | 94,800 | +334.9% | 0.62% | +360.4% |
| Q3 2021 | $555,000 | -27.3% | 21,800 | 0.0% | 0.13% | -33.3% |
| Q2 2021 | $763,000 | -14.1% | 21,800 | 0.0% | 0.20% | -14.5% |
| Q1 2021 | $888,000 | -5.9% | 21,800 | 0.0% | 0.24% | -8.9% |
| Q4 2020 | $944,000 | -21.5% | 21,800 | 0.0% | 0.26% | -33.5% |
| Q3 2020 | $1,202,000 | +84.4% | 21,800 | +122.4% | 0.39% | +78.8% |
| Q2 2020 | $652,000 | +30.9% | 9,800 | 0.0% | 0.22% | -4.4% |
| Q1 2020 | $498,000 | -72.9% | 9,800 | -57.6% | 0.23% | -65.7% |
| Q4 2019 | $1,836,000 | +104.7% | 23,100 | +24.9% | 0.66% | +59.3% |
| Q3 2019 | $897,000 | -39.1% | 18,500 | -33.9% | 0.42% | -24.0% |
| Q2 2019 | $1,472,000 | -0.6% | 28,000 | 0.0% | 0.55% | -0.2% |
| Q1 2019 | $1,481,000 | +164.0% | 28,000 | +36.6% | 0.55% | +156.8% |
| Q2 2017 | $561,000 | -73.7% | 20,500 | -64.7% | 0.21% | -73.9% |
| Q1 2017 | $2,134,000 | – | 58,000 | – | 0.82% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 595,473 | $25,790,000 | 4.19% |
| Grace Capital | 131,549 | $5,697,000 | 3.60% |
| Fernwood Investment Management, LLC | 201,657 | $8,734,000 | 3.44% |
| Fairmount Funds Management LLC | 215,000 | $9,312,000 | 3.33% |
| Arctis Global LLC | 293,700 | $12,720,000 | 2.74% |
| Perceptive Advisors | 5,674,711 | $245,771,000 | 2.64% |
| ArchPoint Investors | 217,510 | $9,420,000 | 2.61% |
| Alerce Investment Management, L.P. | 126,270 | $5,469,000 | 2.15% |
| Profit Investment Management, LLC | 42,196 | $1,826,000 | 1.17% |
| Affinity Asset Advisors, LLC | 50,000 | $2,166,000 | 1.15% |